'Monoclonal antibody' diaporamas de présentation

Quality by Design

Quality by Design. Questions to Consider. How can we maximize the benefits to the industry and other stakeholders? How can we ensure that this will speed up development and reduce the investment for process and product development?

1.54k views • 59 slides

Infected Total Hip Arthroplasty: Diagnosis and Treatment

898 views • 56 slides

Respiratory Pharmacology

Respiratory Pharmacology. Dr Cathy Armstrong Anaesthetic SpR & Clinical Fellow in Undergraduate Medical Education April 2010. Aims & Objectives. Discuss Oxygen therapy Discuss the pharmacological management of: Asthma COPD Inhaler quiz. OXYGEN. Oxygen Therapy. Fixed performance devices

1.15k views • 49 slides

993 views • 49 slides

602 views • 49 slides

Dosage Form Design Lecture 2 19/2/2019 Dr. Athmar Dhahir Habeeb

Dosage Form Design Lecture 2 19/2/2019 Dr. Athmar Dhahir Habeeb PhD in Industrial pharmacy and drug delivery athmar1978@uomustansiriyah.edu.iq athmar1978@yahoo.com a th mar.habeeb.12@ucl.ac.uk. Drug discovery and drug design.

424 views • 29 slides

Burrito Book of Microbiology

Burrito Book of Microbiology. Tales of Tiny Assassins. What Do We Really Need To Know?. basic characteristics how they infect a host what diseases they cause how they can be stopped. How Viruses Attack. Viruses and Bacteria. There is a HUGE difference in their sizes.

374 views • 28 slides

Breast Cancer and Bone Health

419 views • 27 slides

Breast Cancer and Bone Health

571 views • 27 slides

Daclizumab for Asthma: A Business Opportunity Assessment

318 views • 21 slides

Production, Characterization and Use of Chicken IgY Monoclonal Antibodies

Production, Characterization and Use of Chicken IgY Monoclonal Antibodies. Presented by: MUFIDATUR ROSYIDAH (126090100111012). Background. IgA. Chicken Immunoglobulin. IgM. Abundance in Egg Yolk. IgY. Same physiological function in birds = IgG in mammal.

1.13k views • 19 slides

MONOCLONAL ANTIBODIES

MONOCLONAL ANTIBODIES. SEMINAR PRESENTATION Performed by PASCHALIS KOURELIAS MSc BIOMEDICAL IMMUNOLOGY EAST LONDON UNIVERSITY STRATFORD 09 /12/2003 . WELCOME ABOARD. WELCOME TO THE MOST EXCITING DISCOVERY OF MODERN MOLECULAR IMMUNOLOGY.

515 views • 18 slides

AD Clinical Trials: Background and Update

AD Clinical Trials: Background and Update. Navneet Ramesh Renous Meeting 2 /10/ 14. Clinical Trials. Currently about 100 recruiting clinical trials Required for testing of new therapeutic options Limited by: Funding E thical considerations Strict patient requirements.

432 views • 16 slides

Immunology Session 2 Structure and production of a ntibodies

Immunology Session 2 Structure and production of a ntibodies. Immunology Tutorial Outline. 1 Antibody structure Role of antibody in defence Polyclonal antibodies Monoclonal antibodies. 1 revision Antibody structure (p295). Antibody structure (p295). Antibody facts.

672 views • 15 slides

Prions Dormancy and Disease: Can vCJD be Transmitted through Blood Transfusion?

271 views • 13 slides

The New Genetics

337 views • 12 slides

CLS 1113 Introduction to Clinical Laboratory Practices

CLS 1113 Introduction to Clinical Laboratory Practices. Unit 6 Chapter 12. Rheumatoid Arthritis. Similarities to SLE Systemic Age 20-40 Women Mortality Men usually die 4 years earlier than usual Women die 10 years earlier than normal.

193 views • 11 slides

PCSK9 Inhibitors in Development

PCSK9 Inhibitors in Development. mAb = monoclonal antibody Sheridan C. Nature B iotechnology. December 12, 2013; V31:1058.

973 views • 1 slides

Carcinogenic Potential of Wireless Communication Radiation

Carcinogenic Potential of Wireless Communication Radiation. Investigators: James C. Lin, PhD, Electrical and Computer Engineering; and Bioengineering Prime Grant Support: Magnetic Health Science Foundation. Wide Spread Use of Cell Phone Technology Concerns about Health and Safety

76 views • 1 slides

Introduction

No. 078. hENT1 expression in human urothelium ; Evaluating hENT1 prognostic potential for intravesical Gemcitabine treatment outcome in patients with superficial urothelial carcinoma. . Wei Melbourne 1 , Kim Tran 1 , Loreena Johnson 2 , Paul de Souza 3 , William J. Lynch 2

84 views • 1 slides